JPS5813526B2 - ドウブツヨウサツキンソセイブツ - Google Patents
ドウブツヨウサツキンソセイブツInfo
- Publication number
- JPS5813526B2 JPS5813526B2 JP3500874A JP3500874A JPS5813526B2 JP S5813526 B2 JPS5813526 B2 JP S5813526B2 JP 3500874 A JP3500874 A JP 3500874A JP 3500874 A JP3500874 A JP 3500874A JP S5813526 B2 JPS5813526 B2 JP S5813526B2
- Authority
- JP
- Japan
- Prior art keywords
- salts
- cloxacillin
- cefazolin
- grasshopper
- garden
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 241000254032 Acrididae Species 0.000 title 1
- 150000003839 salts Chemical class 0.000 claims description 21
- LQOLIRLGBULYKD-JKIFEVAISA-N cloxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1Cl LQOLIRLGBULYKD-JKIFEVAISA-N 0.000 claims description 11
- 229960003326 cloxacillin Drugs 0.000 claims description 11
- 229960001139 cefazolin Drugs 0.000 claims description 10
- MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- 208000031462 Bovine Mastitis Diseases 0.000 claims description 7
- 239000000645 desinfectant Substances 0.000 claims description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229930182555 Penicillin Chemical class 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical class C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- FLKYBGKDCCEQQM-WYUVZMMLSA-M cefazolin sodium Chemical compound [Na+].S1C(C)=NN=C1SCC1=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 FLKYBGKDCCEQQM-WYUVZMMLSA-M 0.000 description 1
- 229960003408 cefazolin sodium Drugs 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3500874A JPS5813526B2 (ja) | 1974-03-27 | 1974-03-27 | ドウブツヨウサツキンソセイブツ |
| IT6748475A IT1036078B (it) | 1974-03-27 | 1975-02-25 | Composizione antibatterica per anima i |
| AU78654/75A AU490435B2 (en) | 1975-02-27 | Antibacterial composition | |
| DE19752508443 DE2508443C2 (de) | 1974-02-28 | 1975-02-27 | Pharmazeutisches Mischpräparat mit antibiotischer Wirkung |
| FR7506201A FR2262519B1 (enrdf_load_stackoverflow) | 1974-02-28 | 1975-02-27 | |
| GB832775A GB1479838A (en) | 1974-02-28 | 1975-02-27 | Antibacterial composition |
| NL7502333A NL180071C (nl) | 1974-02-28 | 1975-02-27 | Werkwijze voor het bereiden van geneesmiddelen met een antibiotische activiteit. |
| CA221,406A CA1038759A (en) | 1974-03-27 | 1975-03-06 | Mixtures of cephalosporin and penicillin type antibiotics |
| DK132675A DK132675A (enrdf_load_stackoverflow) | 1974-03-27 | 1975-03-26 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3500874A JPS5813526B2 (ja) | 1974-03-27 | 1974-03-27 | ドウブツヨウサツキンソセイブツ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS50126816A JPS50126816A (enrdf_load_stackoverflow) | 1975-10-06 |
| JPS5813526B2 true JPS5813526B2 (ja) | 1983-03-14 |
Family
ID=12430047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3500874A Expired JPS5813526B2 (ja) | 1974-02-28 | 1974-03-27 | ドウブツヨウサツキンソセイブツ |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JPS5813526B2 (enrdf_load_stackoverflow) |
| CA (1) | CA1038759A (enrdf_load_stackoverflow) |
| DK (1) | DK132675A (enrdf_load_stackoverflow) |
| IT (1) | IT1036078B (enrdf_load_stackoverflow) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54126735A (en) * | 1978-03-24 | 1979-10-02 | Toyama Chem Co Ltd | Bactericidal composition for medical use |
| JPH0582374U (ja) * | 1992-04-08 | 1993-11-09 | 元実 原田 | 洋服カバー |
-
1974
- 1974-03-27 JP JP3500874A patent/JPS5813526B2/ja not_active Expired
-
1975
- 1975-02-25 IT IT6748475A patent/IT1036078B/it active
- 1975-03-06 CA CA221,406A patent/CA1038759A/en not_active Expired
- 1975-03-26 DK DK132675A patent/DK132675A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA1038759A (en) | 1978-09-19 |
| DK132675A (enrdf_load_stackoverflow) | 1975-09-28 |
| JPS50126816A (enrdf_load_stackoverflow) | 1975-10-06 |
| IT1036078B (it) | 1979-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Brogden et al. | Aztreonam: a review of its antibacterial activity, pharmacokinetic properties and therapeutic use | |
| Sande et al. | In vivo antagonism between gentamicin and chloramphenicol in neutropenic mice | |
| Weinstein et al. | The effect of urea, urethane and other carbamates on bacterial growth | |
| JPS5813526B2 (ja) | ドウブツヨウサツキンソセイブツ | |
| EP0009686A1 (en) | Antibacterial composition comprising a phosphonic acid derivative | |
| GB1323502A (en) | Erythromycin derivatives | |
| IE51846B1 (en) | Pharmaceutical preparation for veterinary use and an appliance containing it | |
| JP2893650B2 (ja) | 安定剤組成物及び安定化された水性系 | |
| Standiford et al. | Imipenem coadministered with cilastatin compared with moxalactam: integration of serum pharmacokinetics and microbiologic activity following single-dose administration to normal volunteers | |
| US3276956A (en) | Treating infections in poultry caused by pleuropneumoniia-like organisms with erythromycin phosphate | |
| US4199566A (en) | Antibacterial composition for medical use | |
| US4133772A (en) | Aqueous detergent compositions containing amphoteric surfactants having anti-microbial and preservative properties | |
| RU2102075C1 (ru) | Способ получения бактерийного препарата "биосан" | |
| JPH02191205A (ja) | 生物活性組成物 | |
| US4092411A (en) | Antibacterial composition | |
| JPS633846B2 (enrdf_load_stackoverflow) | ||
| US2692845A (en) | Composition containing streptomycin glucuronolactone mixture | |
| US4404189A (en) | Synergistic antimicrobial compositions | |
| Schaller | In vitro antibacterial activity of different clotrimazole formulations. | |
| US4428936A (en) | Antibacterial composition for medical use | |
| STRAKOSCH et al. | Bacteriostatic Effect of Sulfathiazole in Various Ointment Bases | |
| US3141822A (en) | Stable compositions of alkali metal salts of synthetic penicillins and polyacetic acids | |
| US3639632A (en) | Antimicrobial compositions containing 1 1'-hexamethylenebis (5-(2 - ethylhexyl) biguanide) dihydrochloride and 4-chloro-2-hydroxyphenyl 24 - dichlorophenyl ether | |
| Seltzer et al. | The Use of Chloramphenicol (Chloromycetin) for Killing Some Penicillin-Streptomycin Resistant Organisms Encountered in Infected Root Canals | |
| Shibamoto et al. | PHARMACOLOGICAL STUDIES ON CARBAPENEM ANTIBIOTICS I. METABOLISM OF PS-5 IN ANIMAL TISSUES |